GlaxoSmithKline have agreed a deal with BinnoPharm, a Moscow based company, to allow them to make and sell Cervarix, a vaccine which protects against HPV infections, that can cause cervical cancer.
"The local manufacture of these vaccines should help Russia to modernize its National Immunization Calendar in the future, adding additional vaccination against highly prevalent infections," the two firms said in a statement.
Read the full story in the Moscow Times.
No comments:
Post a Comment